| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.67T | 14.72T | 14.03T | 13.95T | 12.29T | 10.36T |
| Gross Profit | 2.43T | 2.38T | 2.23T | 2.13T | 1.94T | 1.78T |
| EBITDA | 1.14T | 867.48B | 871.47B | 863.52B | 736.21B | 558.43B |
| Net Income | 909.07B | 880.25B | 801.77B | 800.52B | 820.27B | 401.43B |
Balance Sheet | ||||||
| Total Assets | 16.55T | 15.13T | 14.49T | 13.11T | 12.15T | 11.18T |
| Cash, Cash Equivalents and Short-Term Investments | 553.82B | 594.68B | 622.48B | 619.27B | 630.39B | 556.98B |
| Total Debt | 5.73T | 5.46T | 5.21T | 4.78T | 4.69T | 5.04T |
| Total Liabilities | 9.66T | 8.84T | 8.50T | 7.65T | 7.39T | 7.31T |
| Stockholders Equity | 6.31T | 5.76T | 5.43T | 4.82T | 4.20T | 3.32T |
Cash Flow | ||||||
| Free Cash Flow | 778.08B | 804.64B | 775.56B | 743.98B | 644.02B | 730.88B |
| Operating Cash Flow | 1.01T | 997.28B | 978.11B | 938.06B | 801.16B | 895.90B |
| Investing Cash Flow | -398.93B | -562.02B | -593.84B | -399.04B | 24.54B | -739.07B |
| Financing Cash Flow | -676.55B | -479.24B | -413.33B | -554.85B | -832.61B | -196.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥9.48T | 14.11 | 13.39% | 2.29% | 9.62% | 25.71% | |
71 Outperform | ¥16.04T | 16.87 | 15.23% | 2.11% | 0.93% | 15.80% | |
69 Neutral | ¥7.12T | 15.10 | 12.86% | 2.48% | 3.19% | 72.26% | |
68 Neutral | ¥21.43T | 13.18 | 7.39% | 2.94% | -7.54% | -35.70% | |
67 Neutral | ¥18.23T | 17.68 | 11.47% | 2.28% | -1.33% | -7.40% | |
65 Neutral | ¥1.21T | 7.20 | 11.17% | 3.24% | 2.12% | 18.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |